These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 23701372

  • 1. Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding: a 6- and 12-month morphological and clinical follow-up.
    Palmara V, Sturlese E, Villari D, Giacobbe V, Retto A, Santoro G.
    Aust N Z J Obstet Gynaecol; 2013 Aug; 53(4):381-5. PubMed ID: 23701372
    [Abstract] [Full Text] [Related]

  • 2. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
    Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O.
    Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
    [Abstract] [Full Text] [Related]

  • 3. A 52-mg levonorgestrel-releasing intrauterine system vs bipolar radiofrequency nonresectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multicenter randomized controlled trial.
    Huijs DPC, Derickx AJM, Beelen P, Leemans JC, van Kuijk SMJ, Bongers MY, Geomini PMAJ.
    Am J Obstet Gynecol; 2024 May; 230(5):542.e1-542.e10. PubMed ID: 38280433
    [Abstract] [Full Text] [Related]

  • 4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A, Hussain M, Rishworth JR, Rees MC.
    Cochrane Database Syst Rev; 2015 Apr 30; (4):CD002126. PubMed ID: 25924648
    [Abstract] [Full Text] [Related]

  • 5. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
    El Behery MM, Saleh HS, Ibrahiem MA, Kamal EM, Kassem GA, Mohamed Mel S.
    Reprod Sci; 2015 Mar 30; 22(3):329-34. PubMed ID: 25001020
    [Abstract] [Full Text] [Related]

  • 6. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S, Hickey M, Chin J, Su HI.
    Cochrane Database Syst Rev; 2015 Dec 09; 2015(12):CD007245. PubMed ID: 26649916
    [Abstract] [Full Text] [Related]

  • 7. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE, Cooke I, Rees M.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD002126. PubMed ID: 16235297
    [Abstract] [Full Text] [Related]

  • 8. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH, Lahti EI, Kauppila AJ, Apaja-Sarkkinen MA, Laatikainen TJ.
    Am J Obstet Gynecol; 1995 Jan 19; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [Abstract] [Full Text] [Related]

  • 9. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI, Suvisaari J, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1997 Jul 19; 68(1):59-64. PubMed ID: 9207585
    [Abstract] [Full Text] [Related]

  • 10. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J, Konje JC, Hickey M.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400
    [Abstract] [Full Text] [Related]

  • 11. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
    Haoula ZJ, Walker KF, Powell MC.
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov 07; 159(1):176-9. PubMed ID: 21741152
    [Abstract] [Full Text] [Related]

  • 12. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
    Beelen P, van den Brink MJ, Herman MC, Geomini PMAJ, Dekker JH, Duijnhoven RG, Mak N, van Meurs HS, Coppus SF, van der Steeg JW, Eising HP, Massop-Helmink DS, Klinkert ER, Nieboer TE, Timmermans A, van der Voet LF, Veersema S, Smeets NAC, Schutte JM, van Baal M, Bossuyt PM, Mol BWJ, Berger MY, Bongers MY.
    Am J Obstet Gynecol; 2021 Feb 07; 224(2):187.e1-187.e10. PubMed ID: 32795428
    [Abstract] [Full Text] [Related]

  • 13. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
    Haimovich S, Checa MA, Mancebo G, Fusté P, Carreras R.
    Menopause; 2008 Feb 07; 15(5):1002-4. PubMed ID: 18451744
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D, Antoniou G, Karakitsos P, Kalogirou O, Antoniou D, Giannikos L.
    Int J Fertil Menopausal Stud; 1996 Feb 07; 41(6):522-7. PubMed ID: 9010746
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation.
    Karimi-Zarchi M, Dehghani-Firoozabadi R, Tabatabaie A, Dehghani-Firoozabadi Z, Teimoori S, Chiti Z, Miratashi-Yazdi A, Dehghani A.
    Clin Exp Obstet Gynecol; 2013 Feb 07; 40(3):421-4. PubMed ID: 24283179
    [Abstract] [Full Text] [Related]

  • 16. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA, Wang S, Rogers P, Vince G, Affandi B.
    Hum Reprod; 1996 Jul 07; 11(7):1438-44. PubMed ID: 8671483
    [Abstract] [Full Text] [Related]

  • 17. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun 07; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 18. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial.
    Gardner FJ, Konje JC, Abrams KR, Brown LJ, Khanna S, Al-Azzawi F, Bell SC, Taylor DJ.
    Lancet; 2000 Nov 18; 356(9243):1711-7. PubMed ID: 11095258
    [Abstract] [Full Text] [Related]

  • 19. Late bleeding problems with the levonorgestrel-releasing intrauterine system: evaluation of the endometrial cavity.
    Rönnerdag M, Odlind V.
    Contraception; 2007 Apr 18; 75(4):268-70. PubMed ID: 17362704
    [Abstract] [Full Text] [Related]

  • 20. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
    Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, Urbauer DL, Ramondetta LM, Schmeler KM, Soliman PT, Fleming ND, Burzawa JK, Nick AM, Milbourne AM, Yuan Y, Lu KH, Bodurka DC, Coleman RL, Yates MS.
    Am J Obstet Gynecol; 2021 Feb 18; 224(2):191.e1-191.e15. PubMed ID: 32805208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.